Scientists probe Melanoma's metabolic tricks to outsmart immunotherapy
NCT ID NCT05307289
First seen Jan 03, 2026 · Last updated May 23, 2026 · Updated 21 times
Summary
This study looks at how melanoma tumors change their metabolism to resist immunotherapy drugs like anti-PD1. Researchers will compare tumor samples from 20 patients whose cancer responds to treatment versus those whose cancer does not. The goal is to find new ways to target cancer cells without harming the immune system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice
RECRUITINGNice, Alpes-maritimes, 06001, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.